| 2024 |
|
| Seznam cyklů EHK Klepněte na kód cyklu jehož vyhodnocení si chcete prohlédnout. |
List of EQA rounds Click a code of the round to access the evaluation. |
| Kód cyklu EHK Code of EQA round |
Datum Date |
Název programu EHK Name of EQA programme |
| ABR1/24 | 22.3.2024 | Parametry acidobazické rovnováhy Acid-base Status and Electrolytes |
| ABR2/24 | 26.7.2024 | |
| ABR3/24 | 22.11.2024 | |
| AIH1/24 | 8.3.2024 | Autoimunitní hepatopatie Autoimmune Liver Diseases |
| AIH2/24 | 18.10.2024 | |
| AIM1/24 | 15.3.2024 | Autoimunita Autoimmunity |
| AIM2/24 | 27.9.2024 | |
| AKS1/24 | 26.1.2024 | Analyty krevního séra Basic Clinical Chemistry - Serum |
| AKS2/24 | 5.4.2024 | |
| AKS3/24 | 26.7.2024 | |
| AKS4/24 | 11.10.2024 | |
| ALB1/24 | 5.4.2024 | Stanovení albuminu v moči Albumin in Urine |
| ALB2/24 | 11.10.2024 | |
| AM1/24 | 5.4.2024 | Analyty moče Basic Clinical Chemistry - Urine |
| AM2/24 | 11.10.2024 | |
| AP1/24 | 29.3.2024 | Antitrombotické přípravky Antithrombotic Agents |
| AP2/24 | 13.9.2024 | |
| APLA1/24 | 15.3.2024 | Antifosfolipidové protilátky Antiphospholipid Antibodies |
| APLA2/24 | 27.9.2024 | |
| AT1/24 | 12.4.2024 | Autoprotilátky u tyreopatií Autoantibodies in Thyroid Diseases |
| AT2/24 | 25.10.2024 | |
| BIL1/24 | 9.2.2024 | Bilirubin novorozenecký Bilirubin Neonatal |
| BIL2/24 | 23.8.2024 | |
| BM1/24 | 12.4.2024 | Kostní markery Bone Markers |
| BM2/24 | 25.10.2024 | |
| CC1/24 | 9.2.2024 | Cystatin C Cystatin C |
| CC2/24 | 23.8.2024 | |
| CD341/24 | 6.5.2024 | Stanovení populace buněk CD34+ Population of CD34+ Cells |
| CD342/24 | 28.10.2024 | |
| CRC1/24 | 30.4.2024 | Kolorektální karcinom Colorectal Carcinoma |
| CRC2/24 | 24.9.2024 | |
| CRP1/24 | 9.2.2024 | Stanovení CRP C-Reactive Protein |
| CRP2/24 | 3.5.2024 | |
| CRP3/24 | 23.8.2024 | |
| CRP4/24 | 29.11.2024 | |
| CRPP1/24 | 26.1.2024 | Stanovení CRP systémy POCT C-Reactive Protein POCT |
| CRPP2/24 | 1.3.2024 | |
| CRPP3/24 | 7.6.2024 | |
| CRPP4/24 | 6.9.2024 | |
| CRPP5/24 | 18.10.2024 | |
| CRPP6/24 | 6.12.2024 | |
| CSFB1/24 | 22.3.2024 | Biochemická analýza likvoru Cerebrospinal Fluid Analysis |
| CSFB2/24 | 22.11.2024 | |
| CSFC1/24 | 22.3.2024 | Cytologie likvoru Cerebrospinal Fluid Cytology |
| CSFC2/24 | 22.11.2024 | |
| CSFF1/24 | 22.3.2024 | Izoelektrická fokusace likvoru Isoelectric Focusing of CSF |
| CSFF2/24 | 22.11.2024 | |
| CSFK1/24 | 22.3.2024 | Klinická analýza likvoru Cerebrospinal Fluid Diagnostics |
| CSFK2/24 | 22.11.2024 | |
| CSH1/24 | 24.5.2024 | Cytochemické barvení v hematologii Cytochemical Staining in Haematology |
| CSH2/24 | 25.10.2024 | |
| DD1/24 | 29.3.2024 | D Dimery D Dimers |
| DD2/24 | 14.6.2024 | |
| DD3/24 | 13.9.2024 | |
| DD4/24 | 15.11.2024 | |
| DGP1/24 | 16.2.2024 | Analýza moče testovacími proužky Urine Strip Tests Analysis |
| DGP2/24 | 3.5.2024 | |
| DGP3/24 | 29.11.2024 | |
| DIF1/24 | 15.3.2024 | Hodnocení nátěru periferní krve Peripheral Blood Morphology Evaluation |
| DIF2/24 | 24.5.2024 | |
| DIF3/24 | 13.9.2024 | |
| DIF4/24 | 25.10.2024 | |
| E11/24 | 2.2.2024 | Endokrinologie 1 Hormones 1 |
| E12/24 | 26.4.2024 | |
| E13/24 | 19.7.2024 | |
| E14/24 | 4.10.2024 | |
| E21/24 | 2.2.2024 | Endokrinologie 2 Hormones 2 |
| E22/24 | 26.4.2024 | |
| E23/24 | 19.7.2024 | |
| E24/24 | 4.10.2024 | |
| FC1/24 | 1.3.2024 | Kalprotektin ve stolici Calprotectin in Stool |
| FC2/24 | 20.9.2024 | |
| FOB1/24 | 3.5.2024 | Okultní krvácení Faecal Occult Blood |
| FOB2/24 | 29.11.2024 | |
| GHP1/24 | 1.3.2024 | Glykovaný hemoglobin POCT Glycated Haemoglobin POCT |
| GHP2/24 | 18.10.2024 | |
| GLC1/24 | 23.4.2024 | Stanovení glukózy (včetně glukometrů) Glucose (including glucometers) |
| GLC2/24 | 5.11.2024 | |
| GP1/24 | 1.3.2024 | Gamapatie Detection of Monoclonal Components |
| GP2/24 | 20.9.2024 | |
| HCB1/24 | 24.5.2024 | Histologické a cytologické barvení Histological and Cytological Staining |
| HCB2/24 | 8.11.2024 | |
| HIL1/24 | 19.4.2024 | Sérové indexy Serum Indices |
| HIL2/24 | 1.11.2024 | |
| HKG1/24 | 29.3.2024 | Hemokoagulace Haemocoagulation Tests |
| HKG2/24 | 14.6.2024 | |
| HKG3/24 | 13.9.2024 | |
| HKG4/24 | 15.11.2024 | |
| HR1/24 | 23.2.2024 | Hormonální receptory Hormonal Receptors |
| HR2/24 | 6.9.2024 | |
| HS1/24 | 14.6.2024 | Hemokoagulace speciální Haemocoagulation Special |
| HS2/24 | 15.11.2024 | |
| IDDM1/24 | 8.3.2024 | Autoimunitní diabetes 1. typu Type 1 Autoimmune Diabetes |
| IDDM2/24 | 18.10.2024 | |
| IFT1/24 | 22.4.2024 | Imunofenotypizace Immunophenotypisation |
| IFT2/24 | 28.10.2024 | |
| IGIT1/24 | 8.3.2024 | Imunopatologie GIT Immunopathology of GIT |
| IGIT2/24 | 18.10.2024 | |
| IH1/24 | 8.3.2024 | Imunohematologie Blood Group Serology |
| IH2/24 | 31.5.2024 | |
| IH3/24 | 27.9.2024 | |
| IH4/24 | 15.11.2024 | |
| IHC1/24 | 23.2.2024 | Imunohistochemie - detekce HER-2/neu Immunohistochemistry - Detection of HER-2/neu |
| IHC2/24 | 6.9.2024 | |
| INRP1/24 | 1.3.2024 | Měření INR systémy POCT INR measurement on POCT |
| INRP2/24 | 7.6.2024 | |
| INRP3/24 | 6.9.2024 | |
| INRP4/24 | 18.10.2024 | |
| KD1/24 | 26.1.2024 | Glykovaný hemoglobin Glycated Haemoglobin |
| KD2/24 | 5.4.2024 | |
| KD3/24 | 26.7.2024 | |
| KD4/24 | 1.11.2024 | |
| KM1/24 | 9.2.2024 | Kardiální markery Cardiac Markers |
| KM2/24 | 23.8.2024 | |
| KO1/24 | 8.3.2024 | Krevní obraz Blood Count |
| KO2/24 | 12.4.2024 | |
| KO3/24 | 17.5.2024 | |
| KO4/24 | 21.6.2024 | |
| KO5/24 | 6.9.2024 | |
| KO6/24 | 20.9.2024 | |
| KO7/24 | 4.10.2024 | |
| KO8/24 | 18.10.2024 | |
| LMWH1/24 | 29.3.2024 | Nízkomolekulární heparin Low Molecular Weight Heparin |
| LMWH2/24 | 13.9.2024 | |
| MS1/24 | 16.2.2024 | Močový sediment Urinary Sediment Morphology |
| MS2/24 | 3.5.2024 | |
| MS3/24 | 29.11.2024 | |
| NF1/24 | 15.3.2024 | Nátěr periferní krve - fotografie Peripheral Blood Smears - Photos |
| NF2/24 | 13.9.2024 | |
| NKDF1/24 | 26.4.2024 | Nátěr kostní dřeně - fotografie Bone Marrow Aspirate Film |
| NKDF2/24 | 4.10.2024 | |
| PAT1/24 | 31.5.2024 | Přímý antiglobulinový test Direct Antiglobulin Test |
| PAT2/24 | 15.11.2024 | |
| PDL11/24 | 11.6.2024 | Programmed Death Ligand 1 Programmed Death Ligand 1 |
| PDL12/24 | 12.11.2024 | |
| PIG1/24 | 8.3.2024 | Podtřídy IgG IgG subclasses |
| PIG2/24 | 18.10.2024 | |
| PRO1/24 | 1.3.2024 | Proteiny v krevním séru Specific Proteins |
| PRO2/24 | 20.9.2024 | |
| RET1/24 | 19.4.2024 | Retikulocyty Reticulocytes |
| RET2/24 | 27.9.2024 | |
| RF1/24 | 15.3.2024 | Diagnostika revmatoidní artritidy a ASLO Diagnostics of Rheumatoid Arthritis and ASLO |
| RF2/24 | 27.9.2024 | |
| RFA1/24 | 5.4.2024 | Rizikové faktory aterosklerózy Risk Factors for Atherosclerosis |
| RFA2/24 | 11.10.2024 | |
| SED1/24 | 29.3.2024 | Sedimentační rychlost erytrocytů Erythrocyte Sedimentation Rate |
| SED2/24 | 13.9.2024 | |
| T05/24 | 22.4.2024 | Imunofenotypizace (studie) Immunophenotypisation (study) |
| T09/24 | 27.9.2024 | anti-GBM (studie) anti-GBM (study) |
| TDM1/24 | 26.4.2024 | Léky Therapeutic Drugs |
| TDM2/24 | 4.10.2024 | |
| TE1/24 | 5.3.2024 | Stanovení stopových prvků Trace Elements |
| TE2/24 | 24.9.2024 | |
| TIE1/24 | 1.3.2024 | Stanovení celkového IgE Allergy Control Scheme (Total IgE) |
| TIE2/24 | 20.9.2024 | |
| TM1/24 | 6.2.2024 | Tumorové markery Tumour Markers |
| TM2/24 | 30.4.2024 | |
| TM3/24 | 23.7.2024 | |
| TM4/24 | 8.10.2024 | |
| VIB1/24 | 24.5.2024 | Všeobecná imunohistochemie - barvení General Immunohistochemistry - Staining |
| VIB2/24 | 8.11.2024 | |
| VVV1/24 | 19.4.2024 | Diagnostika vrozených vývojových vad Maternal Diagnostic Screening (Triple Test) |
| VVV2/24 | 1.11.2024 |